Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., et al. (2020) 2019 ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes. European Heart Journal, 41, 407-477.

has been cited by the following article:

• TITLE: Conservative Approach Might Be the Strategy by Default in Stable Angina Patients: A Case Report

  AUTHORS: Serigne Cheikh Tidiane Ndao, Mame Madjiguene Ka, Djibril Marie Ba, Khadidiatou Dia, Mouhamed Chérif Mboup, Pape Diadie Fall

  KEYWORDS: Stable Angina, Chronic Coronary Syndrome, Conservative Treatment, Case Report

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.10 No.11, November 25, 2020

  ABSTRACT: Management of stable angina is still a matter of debate. Whether a conservative or invasive approach is better remains unclear. Even though recent large-scale randomized trials depict the conservative strategy as safe and efficient. In this report, we present a case of a 53-year-old male patient with cardiovascular risk factors of hypertension and hypercholesterolemia. He complained about typical chest pain at exertion. The coronary angiogram (CA) revealed severe stenosis of the proximal left anterior descending artery (LAD) ostium. After heart team discussion, coronary artery bypass graft (CABG) was advocated. However, due to a lack of means, the CABG was postponed. Meanwhile, he was managed with guideline-based medical therapy. In addition, he exercised regularly and adopted a healthy diet. Evolution was favorable with excellent symptoms control. A regular follow-up was organized with his cardiologist. A new CA before an eventual CABG six years later showed a significant plaque volume regression of the proximal LAD. We decided to continue conservative management. The stress echocardiogram to assess symptoms and exercise tolerance was normal. Our patient was sent to surgery on top of optimal medical therapy even though angioplasty was a good indication and was feasible. However, while he was struggling to afford the CABG procedure, he adopted a very healthy lifestyle along with medical therapy. Six years later, the result of that approach was without appeal, suggesting and reinforcing the conservative management of stable heart disease over invasive strategy. The recent ISCHEMIA trial is a major argument supporting that approach.